Servier Canada Release: Once-Daily Anticoagulant LIXIANA (Edoxaban) Approved In Canada For Stroke Prevention In Atrial Fibrillation And For The Treatment And Prevention Of Recurrent Deep-Vein Thrombosis And Pulmonary Embolism